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Background: Diagnosis of pediatric autoimmune gastritis (AIG) in children is important
due to poor outcome and risk of malignancy. This condition is often underestimated
in the clinico-pathologic diagnostic work-up, leading to delayed time-to-diagnosis. To
increase the awareness of this condition in the pediatric population, we present two
cases encountered at our institution, discuss their clinical, biological, and histological
presentations in relation with evidence from the literature, and propose an algorithm for
diagnosis and follow-up of AIG in children.
Case presentation: Two patients (12 and 17 years old) presented with iron deficiency
anemia and negative family history for autoimmune disorders. In both cases, the
final diagnosis of autoimmune gastritis was delayed until pathological examination of
endoscopic gastric biopsies showed atrophy of oxyntic glands. Helicobacter pylori
search was negative. Follow up biopsies revealed persistent disease. Literature review
on this condition shows unclear etiology and poor long term outcome in some patients
because of increased risk of malignancy.
Conclusions: AIG should be considered in the differential diagnosis of iron
deficiency anemia in the pediatric population.Standardized clinico-pathologic work-up
is mandatory. Endoscopic follow-up should be performed due to the risk of malignancy.
Keywords: autoimmune gastritis, gastric atrophy, children, intestinal metaplasia, ECL cell hyperplasia, iron-
deficiency anemia
BACKGROUND
Autoimmune gastritis (AIG) is a chronic progressive inflammatory condition that is characterized
by destruction of oxyntic glands and their replacement by atrophic and metaplastic mucosa,
typically accompanied by lymphoplasmacytic infiltration of the lamina propria. The decrease or
disappearance of parietal cells results in hypochlorhydria or achlorhydria and loss of intrinsic
factor, which interfere with intestinal absorption of iron and vitamin B12, respectively (1).
Iron and vitamin B12 malabsorption is responsible for a spectrum of clinical signs and laboratory
Abbreviations: AIG, autoimmune gastritis; IDA, iron-deficiency anemia; ECL, enterochromaffin-like
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alterations, including iron-deficiency (IDA), and megaloblastic
anemia. Moreover, increased gastric pH relieves somatostatin-
mediated inhibition of antral gastrin-producing cells, and
the ensuing hypergastrinemia induces proliferation of
enterochromaffin-like (ECL) cells, which may give rise to
neuroendocrine tumors (2–4).
Although it has traditionally been considered as a disease
predominantly affecting elderly women of Northern European
descent, recent clinical reports have described this condition
in pediatric patients, especially in association with refractory
iron-deficiency anemia and other autoimmune diseases (5–14).
CASE PRESENTATION
Case 1
A 12-year-old girl with a history of paleness, epigastric pain
and menorrhagia, and no previous personal or family history of
autoimmune disease, was referred to our hospital to evaluate a
microcytic hypochromic anemia (Hb = 10.6 g/dl; MCV = 64
fl; MCH = 19.4 pg; MCHC = 302 g/l; iron = 2.7 µmol/l;
ferritin = 6 µg/l) unresponsive to oral iron treatment. Because
of positive fecal occult blood test and elevated fecal calprotectin
(705µg/g), she underwent upper and lower endoscopy, to
look for sources of gastrointestinal bleeding. Colonoscopy and
histological examination of colonic biopsies taken during the
procedure were unremarkable. Upper endoscopy imaging was
also unremarkable, but the histological examination revealed
chronic atrophic gastritis at both fundic and antral level.
Specifically, fundic biopsies showed a complete atrophy of
the oxyntic glands and intestinal metaplasia, accompanied by
a moderate inflammatory infiltrate composed of lymphocytes,
plasma cells, eosinophils, and rare neutrophils. Linear and
micronodular hyperplasia of ECL cells was demonstrated with
immunohistochemical staining for chromogranin A. Antral
biopsies exhibited a moderate chronic atrophic gastritis, without
FIGURE 1 | Case n.1 histological examination of gastric biopsies. At morphological analysis, fundic mucosa showed severe chronic gastritis, characterized by
complete atrophy of the oxyntic glands and intestinal metaplasia, and lymphoplasmacytic predominant inflammatory infiltrate (A, H&E stain, 10x). Imunohistochemical
staining for chromogranin A of the same biopsy demonstrated linear and micronodular hyperplasia of the ECL cells (B, chromogranin A stain, 20x).
inflammatory activity and intestinal metaplasia. Helicobacter
pylori search was negative after Giemsa-stained special coloration
and immunohistochemical staining with anti-Helicobacter pylori
specific antibody. A representative picture of these histological
findings is shown in Figure 1.
Fecal H. pylori antigen test was positive, and the patient
received a triple therapy with amoxicillin, clarithromycin for
14 days and esomeprazole for 1 month. Subsequent fecal
antigen negative test confirmed H. pylori eradication. However,
in a follow-up upper endoscopy performed 15 months later,
histological examination proved unmodified. AIG was confirmed
after further laboratory investigations revealing the presence of
anti-parietal cell antibodies (1/1280 titer). Anti-intrinsic factor
antibodies were negative and vitamin B12 levels were normal
(164 pmol/l). Serum gastrin level was not assessed, as the patient
was on esomeprazole, and urinary methylmalonic acid and
homocysteine levels were not tested.
Case 2
A 17-year-old girl with a history of menorrhagia, fatigue
and dizziness, and no previous personal or family history of
autoimmune disease, was referred to our hospital to evaluate
an IDA (Hb = 6.7 g/dl; MCV = 56 fl; MCH = 16.1 pg;
MCHC = 288 g/l; iron = 8.1 µmol/l) unresponsive to oral iron
supplementation. Again, colonoscopy and upper endoscopy were
unremarkable, but histological examination of gastric biopsies
revealed chronic atrophic gastritis.
Specifically, fundic biopsies showed complete atrophy
of the oxyntic glands, with pseudo-pyloric metaplasia,
accompanied by a mild inflammatory infiltrate composed
of lymphocytes and plasma cells; micronodular hyperplasia
of ECL cells was demonstrated with immunohistochemical
staining for chromogranin A. H. pylori search was negative after
Giemsa-stained special coloration and immunohistochemical
staining with Anti-Helicobacter pylori specific antibody. Only
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FIGURE 2 | Case n.2 histological examination of gastric biopsies. At morphological analysis, fundic mucosa showed mild chronic gastritis, characterized by complete
atrophy of the oxyntic glands and pseudopyloric metaplasia (A, H&E stain, 10x). Imunohistochemical staining for chromogranin A of the same biopsy demonstrated
linear and micronodular ECL cell hyperplasia (B, chromogranin A stain, 10x).
mild chronic inflammation was observed in the antrum. A
representative picture of these histological findings is shown in
Figure 2.
After 7 months, a follow-up upper endoscopy histological
examination demonstrated persisting fundic chronic atrophic
gastritis with linear and micronodular hyperplasia of ECL.
AIG was confirmed after further laboratory investigations
revealing the presence of anti-parietal cell antibodies (1/2560
titer). Anti-intrinsic factor antibodies, as well as celiac disease
or autoimmune thyroiditis specific serological tests, were
negative. Vitamin B12 levels were normal (257 pmol/l). Urinary
methylmalonic acid and homocysteine levels were not tested.
DISCUSSION AND CONCLUSIONS
In the cases reported here, AIG was a late and unexpected
discovery in the diagnostic workup of a refractory anemia. This
is in accordance with other previously published pediatric cases
(Table 1), for which upper endoscopy was often delayed, in the
context of refractory IDA, epigastric pain, or in the follow-up of
other autoimmune diseases (6, 9, 11–16).
When considering the whole of all pediatric patients reported
in the literature, the average age at the diagnosis was 12.3
years, ranging from 8 months to 18 years. The most common
presentations were refractory or recurrent IDA, followed by
non-specific gastrointestinal symptoms. To further complicate
the diagnosis, reported endoscopic findings were non-specific
in most cases, and coexistence of positive anti-gastric parietal
cells antibodies, vitamin B12 deficiency, and hypergastrinemia
were present only in a minority of patients. Therefore, as in
our cases, histologic examination was often the first analysis
suggesting the possibility of AIG (9). It should be stressed
that AIG is, by definition, a pathological process of the gastric
body. Therefore, in the routine diagnostic workup of IDA,
the clinician should always submit endoscopic biopsies from
the gastric body and from the gastric antrum separately for
pathological analysis. In the absence of fundic lesions, atrophia,
and metaplastic changes occurring in the antrum are not a sign
of AIG. Furthermore, fundic origin of the submitted biopsies has
to be correctly identified by pathologists and special attention
has to be paid not to misinterpret complete fundic atrophia as
an antral specimen. For this specific purpose, a negative gastrin
immunohistochemical staining can help to confirm the fundic
origin of the samples. H. pylori infection, which is, to the best of
our knowledge, the only differential diagnosis to consider should
be attentively investigated, clinically, and pathologically.
As far as hematological alterations are concerned, pernicious
anemia is not the only manifestation associated with AIG:
by stratifying patients with AIG according to age, Hershko
et al. suggested that IDA is the most frequent hematological
presentation in young patients, and that there is a progressive
increase in mean corpuscular volume and severity of vitamin
B12 deficiency with advancing age at presentation (5). Young
patients presenting withmicrocytic anemia are almost exclusively
women, thus implying that menstrual blood loss may have a
role in the development of iron deficiency, aggravated by the
inability to increase food iron absorption due to hypochlorhydria.
In effect, both of our patients had a history of menorrhagia, which
could have contributed to their anemia (5).
The study of Hershko et al. has also shown a high
prevalence of H. pylori positivity in young patients with AIG
and microcytic anemia. Although the most common trigger
of AIG in adults is H. pylori infection, with mechanisms of
molecular mimicry hypothesized as initiating event of gastric
autoimmunity on the basis of cross-reaction between H. pylori
antigens and gastric H+,K+-ATPase, AIG appears to be a late
complication of infection, as any ECL cell hyperplasia that
may arise in that context (17). Therefore, the role of H. pylori
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FIGURE 3 | Algorithm suggested for the diagnosis and follow-up of pediatric autoimmune gastritis.
infection in pathogenesis of AIG in pediatric population remains
controversial. Although some authors have described remission
of autoimmune atrophic gastritis after eradication of H. pylori
infection in adults, we did not observe any improvement in
gastric atrophy of our first patient after eradication therapy (18).
The same observation was made by other authors who followed-
up pediatric patients with H. pylori infection and AIG (9, 10).
However, as H. pylori eradication is a simple procedure most of
the times, regular search and treatment in case of positivity are
recommended (8).
The long-term outcome of AIG in children has not been
investigated yet. Our findings, in line with those of other authors,
have shown no improvement in gastric atrophy, metaplasia,
or ECL cell hyperplasia over time, consistently with known
progression of AIG in adult patients (3, 4, 8, 10).
AIG is associated with intestinal-type gastric cancer and
type I neuroendocrine tumors (3, 4). Consequently, it
deserves particular attention as a preneoplastic condition
in children, considering their long life expectancy. Different
pathophysiological mechanisms are involved in the development
of such gastric tumors: a pathological sequence of events
progressing through inflammation, metaplasia and dysplasia
ultimately results in intestinal-type gastric adenocarcinoma;(1)
gastrin acts as a growth factor for ECL cells, and hypergastrinemia
caused by achlorhydria induces ECL cell proliferations, which
can develop into neuroendocrine tumor. In addition, ECL
cells produce histamine, basic fibroblast growth factor and
Reg protein, which are well-established to have trophic effects;
therefore, it is reasonable to hypothesize that neuroendocrine
cells play a role also in the pathogenesis of gastric cancer of
the intestinal type (2). In published reports about neoplastic
evolution of gastric atrophy in the pediatric population, one
patient developed gastric adenocarcinoma at the age of 17 years,
8 years after initial diagnosis of AIG;(9) one patient developed a
poorly differentiated gastric adenocarcinoma at 17 years, two and
a half year after initial diagnosis;(11) a further patient presented
at first upper endoscopy with a gastric neuroendocrine tumor in
a background of autoimmune atrophic gastritis at the age of 14
(7).
Since no curative therapy is available for AIG, treatment
of this condition is focused on preventing vitamin B12 and
iron deficiencies. Since dietary and oral iron supplements
do not usually improve iron levels, alternative iron therapy
approaches such as intravenous iron oral supplementation of
ferrous glycine sulfate can be proposed (19). To date, the
endoscopic follow up of AIG is still matter of debate and no
specific guidelines for the pediatric population are available. For
the adult population, the American Society for Gastrointestinal
Endoscopy recommended in 2006 a single endoscopic evaluation
for neoplastic lesions after diagnosis of AIG but no routine
follow-up, while the guidelines from the European Society
of Gastrointestinal Endoscopy recommends that once the
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diagnosis of AIG is established, follow-up endoscopies should
be performed every 3 years to screen for the development of
gastric malignancies (20, 21). Due to the longer life expectancy
of the pediatric population and considering the relatively
high risk of malignant transformation, surveillance protocols
should be put in place for these patients. An algorithm for
the diagnosis and follow-up of pediatric AIG is suggested in
Figure 3.
In conclusion, physicians and pathologists should be aware
of AIG existence also in the pediatric population. The
histopathological examination can shorten the diagnostic delay,
provided that adequate sampling of the stomach with body and
antrum biopsies sent separately is performed. Poor outcome and
risk of malignancy should be considered in the management
strategy of these patients, taking into account their long life
expectancy.
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